Middle East & Africa Antibiotics Market Size & Outlook
Related Markets
MEA antibiotics market highlights
- The MEA antibiotics market generated a revenue of USD 1,892.6 million in 2024.
- The market is expected to grow at a CAGR of 1.9% from 2025 to 2033.
- In terms of segment, cell wall synthesis inhibitors was the largest revenue generating action mechanism in 2024.
- RNA Synthesis Inhibitors is the most lucrative action mechanism segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 1,892.6 million |
| Market revenue in 2033 | USD 2,315.1 million |
| Growth rate | 1.9% (CAGR from 2025 to 2033) |
| Largest segment | Cell wall synthesis inhibitors |
| Fastest growing segment | RNA Synthesis Inhibitors |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors |
| Key market players worldwide | AbbVie Inc, Pfizer Inc, Novartis AG ADR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Lupin, Viatris Inc, Melinta Therapeutics, Cipla Ltd DR, Shionogi & Co Ltd, GSK PLC, Kyorin Pharmaceutical, Nabriva Therapeutics |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.6% of the global antibiotics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 18,609.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotics Market Scope
Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nabriva Therapeutics | View profile | 101-250 | Vienna, Wien, Austria, Europe | http://www.nabriva.com |
| Kyorin Pharmaceutical | View profile | 1001-5000 | Tokyo, Tokyo, Japan, Asia | https://www.kyorin-pharm.co.jp |
| Shionogi & Co Ltd | View profile | 6204 | 1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan, 541-0045 | http://www.shionogi.co.jp |
| Melinta Therapeutics | View profile | 101-250 | New Haven, Connecticut, United States, North America | http://melinta.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotics market will help companies and investors design strategic landscapes.
Cell wall synthesis inhibitors was the largest segment with a revenue share of 53.92% in 2024. Horizon Databook has segmented the Middle East & Africa antibiotics market based on cell wall synthesis inhibitors, protein synthesis inhibitors, dna synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa antibiotics market databook
-
Our clientele includes a mix of antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa antibiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa antibiotics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA antibiotics market size, by country, 2021-2033 (US$M)
Middle East & Africa Antibiotics Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
